| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,768 | 11,913 | 10,892 | 13,627 | | Cost of Revenue | 4,429 | 3,793 | 4,666 | 4,463 | | | Gross Profit | 8,339 | 8,120 | 6,226 | 9,164 | | | Operating Expenses | | Research Development | 3,014 | 3,386 | 3,663 | 3,650 | | Selling General and Administrative | 5,195 | 4,350 | 5,602 | 7,872 | | Non Recurring | 1,536 | 805 |
-
|
-
| | Others | 125 | 125 | 125 | 125 | | | | Total Operating Expenses | 9,870 | 8,666 |
-
|
-
| | | | Operating Income or Loss | (1,531) | (546) | (3,164) | (2,483) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (42) | | Earnings Before Interest And Taxes | (1,878) | (546) | (3,164) | (2,525) | | Interest Expense | (137) | 51 | 86 | 111 | | Income Before Tax | (1,741) | (597) | (3,250) | (2,636) | | Income Tax Expense | 31 | 10 | 16 | (84) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,772) | (607) | (3,266) | (2,552) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,772) | (607) | (3,266) | (2,552) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,772) | ($607) | ($3,266) | ($2,552) |
|
0.22% Nasdaq 0.00%
Income Statement
